Nordgren Week 4 Flashcards
Cardiac effects of amiodarone
blocks K channels, prolongs AP (also a potent Na+ channel blocker, and weak blocker of B-receptors and Ca channels to slow HR and AV node conduction)
Amiodarone extracardiac effects
causes peripheral vasodilation
Toxicity of Amiodarone
bradycardia and heart block in pts with preexisting SA or AV node ds; drug accumulates in tissues (heart, lung, liver, skin, tears) blocks peripheral conversion of T4 to T3 and source of inorganic iodine
Pharmacokinetics of Amiodarone
hepatic metabolism; major metabolite is bioactive; complex elimination T1/2 1-3 months past cessation and measurable in tissue up to year
Where is Amiodarone metabolized?
CYP3A4
What other drugs does Amiodarone cause increased levels of via P450?
statins, digoxin, warfarin
Therapeutic use of Amiodarone?
ventricular tachycardia, including ventricular fibrillation, atrial fibrillation and flutter
Black Box Warning on Amiodarone
dose related pulmonary toxicity; abnormal liver function, hypersensitivity hepatitis, skin deposits (photodermatitis, gray-blue skin discoloration in sun-exposed areas), corneal microdeposits (in nearly all patients), halos develope in peripheral visual fields, rarely optic neuritis leading to blindness and hypo or hyperthyroidism
Cardiac effects of Dofetilide (Class III K+ channel blocker)
Very selective K+ channel blocker. Prolongs AP. The increase in QT interval observed is a result of prolongation of refractory period in the His-Purkinje system and ventricles.
Toxicity of Dofetilide (Class III K+ channel blocker)
Can cause life-threatening ventricular arrhythmias
Pharmacokinetics (Class III K+ channel blocker)
100% bioavailable! Hepatic metabolism via CPY3A4.
Therapeutic Use (Class III K+ channel blocker)
Maintenance and restoration of normal sinus rhythm in atrial fibrillation. Contraindicated in long QT, bradycardia, hypokalemia.
Cardiac effects of Ibutilide (Class III K+ channel blocker)
Prolongs AP. Also slow inward Na+ activator, which delays repolarization inhibits Na+ channel inactivation, which increases ERP
Toxicity of
Ibutilide (Class III K+ channel blocker)
Excessive QT-interval prolongation and torsades de pointes. Can cause life-threatening ventricular arrhythmias.
Pharmacokinetics of Ibutilide (Class III K+ channel blocker)
hepatic metabolism
Therapeutic Use of Ibutilide (Class III K+ channel blocker)
Acute conversion of atrial flutter and fibrillation to normal sinus rhythm. More effective in flutter… mean time to termination = 20 min.
Cardiac effects of Verapamil (Class IV Antiarrhythmic Ca Channel Blocker)
Blocks both activated and inactivated L-type Ca2+ channels, so greater affect in tissues that fire frequently, those less polarized, or nodal tissue.
Extracardiac effects of Verapamil (Class IV Antiarrhythmic Ca Channel Blocker)
peripheral vasodilation
Toxicity of Verapamil (Class IV Antiarrhythmic Ca Channel Blocker)
Large doses can induce AV block, or when used in patients with AV nodal disease. Constipation, lassitude, nervousness, peripheral edema.
Pharmacokinetics Verapamil (Class IV Antiarrhythmic Ca Channel Blocker)
hepatic metabolism
Therapeutic Use of Verapamil (Class IV Antiarrhythmic Ca Channel Blocker)
Supraventricular tachycardia, atrial fibrillation and flutter (reduces ventricular rate, not convert back to sinus rhythm), occasionally ventricular arrhythmias. Contraindicated in Wolff-Parkinson-White.
Cardiac effects of Diltiazem (Class IV Antiarrhythmic Ca Channel Blocker)
Similar to verapamil but with more smooth muscle-relaxing effect and produces less bradycardia.
Adenosine (Class V Antiarrhythmic)
increase K+ out of cells to hyperpolarizing the cell and decrease I calcium
Effect of Verapamil on QRS
increased PR interval
Effect of Ibutilide, Dofetilide (Class III K+ channel blocker)
increased QT interval
What is the drug of choice in diagnosing/terminating certain forms of SVT?
adenosine
What is the duration of action of adenosine?
15 seconds